Title
|
|
|
|
The role of c-Met as a biomarker and player in innate and acquired resistance in non-small-cell lung cancer : two new mutations warrant further studies
| |
Author
|
|
|
|
| |
Abstract
|
|
|
|
The c-Met receptor is a therapeutically actionable target in non-small-cell lung cancer (NSCLC), with one approved drug and several agents in development. Most suitable biomarkers for patient selection include c-Met amplification and exon-14 skipping. Our retrospective study focused on the frequency of different c-Met aberrations (overexpression, amplification and mutations) in 153 primary, therapy-naive resection samples and their paired metastases, from Biobank@UZA. Furthermore, we determined the correlation of c-Met expression with clinicopathological factors, Epidermal Growth Factor Receptor (EGFR)-status and TP53 mutations. Our results showed that c-Met expression levels in primary tumors were comparable to their respective metastases. Five different mutations were detected by deep sequencing: three (E168D, S203T, N375S) previously described and two never reported (I333T, G783E). I333T, a new mutation in the Sema(phorin) domain of c-Met, might influence the binding of antibodies targeting the HGF-binding domain, potentially causing innate resistance. E168D and S203T mutations showed a trend towards a correlation with high c-Met expression (p = 0.058). We found a significant correlation between c-MET expression, EGFR expression (p = 0.010) and EGFR mutations (p = 0.013), as well as a trend (p = 0.057) with regards to TP53 mutant activity. In conclusion this study demonstrated a strong correlation between EGFR mutations, TP53 and c-Met expression in therapy-naive primary resection samples. Moreover, we found two new c-Met mutations that warrant further studies. |
| |
Language
|
|
|
|
English
| |
Source (journal)
|
|
|
|
Molecules: a journal of synthetic chemistry and natural product chemistry. - Bazel
| |
Publication
|
|
|
|
Bazel
:
2019
| |
ISSN
|
|
|
|
1420-3049
| |
DOI
|
|
|
|
10.3390/MOLECULES24244443
| |
Volume/pages
|
|
|
|
24
:24
(2019)
, 15 p.
| |
Article Reference
|
|
|
|
4443
| |
ISI
|
|
|
|
000507299600021
| |
Pubmed ID
|
|
|
|
31817278
| |
Medium
|
|
|
|
E-only publicatie
| |
Full text (Publisher's DOI)
|
|
|
|
| |
Full text (open access)
|
|
|
|
| |
|